Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Rises By 27.0%

BetterLife Pharma Inc. (OTCMKTS:BETRFGet Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 58,800 shares, an increase of 27.0% from the March 15th total of 46,300 shares. Based on an average daily volume of 90,100 shares, the short-interest ratio is currently 0.7 days.

OTCMKTS:BETRF opened at $0.11 on Monday. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.06. BetterLife Pharma has a fifty-two week low of $0.09 and a fifty-two week high of $0.72. The firm’s 50 day moving average is $0.13 and its two-hundred day moving average is $0.18.

About BetterLife Pharma (Get Rating)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus.

See Also

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.